Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Author Last Name:
Title Keyword(s):
June 2019. Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans. Lampe JW, Kim E, Levy L, Davidson LA, Goldsby JS, Miles FL, Navarro SL, Randolph TW, Zhao N, Ivanov I, Kaz AM, Damman C, Hockenbery DM, Hullar MAJ, Chapkin RS. Am J Clin Nutr. 2019 Jun 8. pii: nqy325. doi: 10.1093/ajcn/nqy325. [Epub ahead of print]
May 2019. Screening flexible sigmoidoscopy versus colonoscopy for reduction of colorectal cancer mortality. Ko CW, Doria-Rose VP, Barrett MJ, Kamineni A, Enewold L, Weiss NS. Int J Colorectal Dis. 2019 May 31. doi: 10.1007/s00384-019-03300-7. [Epub ahead of print]
May 2019. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification. Ioannou GN, Green P, Kerr KF, Berry K. J Hepatol. 2019 May 27. pii: S0168-8278(19)30291-0. doi: 10.1016/j.jhep.2019.05.008. [Epub ahead of print]
May 2019. PET Imaging of [<sup>11</sup> C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporine A. Billington S, Shoner S, Lee S, Clark-Snustad K, Pennington M, Lewis D, Muzi M, Rene S, Lee J, Nguyen TB, Kumar V, Ishida K, Chen L, Chu X, Lai Y, Salphati L, Hop CECA, Xiao G, Liao M, Unadkat JD. Clin Pharmacol Ther. 2019 May 18. doi: 10.1002/cpt.1506. [Epub ahead of print]
May 2019. Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, Janneke van der Woude C, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C. Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30523-3. doi: 10.1016/j.cgh.2019.05.013. [Epub ahead of print]
May 2019. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. Alley K, Singla A, Afzali A. Inflamm Bowel Dis. 2019 May 14. pii: izz100. doi: 10.1093/ibd/izz100. [Epub ahead of print]
May 2019. Incidence of Advanced Colorectal Neoplasia in Individuals With Untreated Diminutive Colorectal Adenomas Diagnosed by Magnifying Image-Enhanced Endoscopy. Sekiguchi M, Otake Y, Kakugawa Y, Matsumoto M, Tomizawa Y, Saito Y, Matsuda T. Am J Gastroenterol. 2019 May 10. doi: 10.14309/ajg.0000000000000261. [Epub ahead of print]
May 2019. Listing practices and graft utilization of hepatitis C-positive deceased donors in liver and kidney transplant. Kling CE, Perkins JD, Biggins SW, Johnson CK, Limaye AP, Sibulesky L. Surgery. 2019 May 6. pii: S0039-6060(19)30166-7. doi: 10.1016/j.surg.2019.03.015. [Epub ahead of print]
May 2019. Editorial: benefits of HCV eradication beyond the liver. Ioannou GN. Aliment Pharmacol Ther. 2019 May;49(10):1364-1365. doi: 10.1111/apt.15261.
May 2019. Predicting outcomes in lower gastrointestinal bleeding: more work ahead. Kosowicz RL, Strate LL. Gastrointest Endosc. 2019 May;89(5):1014-1016. doi: 10.1016/j.gie.2019.01.020.
1 - 10 Next
©2016-2018 University of Washington Division of Gastroenterology
1959 NE Pacific St., Box 356424, Seattle, WA 98195-6424
Contact Us | Privacy | Terms | Copyright & Disclaimer